Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells

Bromodomain-containing proteins (BRDs) are involved in many biological processes, most notably epigenetic regulation of transcription, and BRD dysfunction has been linked to many diseases, including tumorigenesis. However, the role of BRDs in the pathogenesis of uterine fibroids (UFs) is entirely un...

Full description

Bibliographic Details
Main Authors: Qiwei Yang, Somayeh Vafaei, Ali Falahati, Azad Khosh, Maria Victoria Bariani, Mervat M. Omran, Tao Bai, Hiba Siblini, Mohamed Ali, Chuan He, Thomas G. Boyer, Ayman Al-Hendy
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/2/905
_version_ 1797339828448133120
author Qiwei Yang
Somayeh Vafaei
Ali Falahati
Azad Khosh
Maria Victoria Bariani
Mervat M. Omran
Tao Bai
Hiba Siblini
Mohamed Ali
Chuan He
Thomas G. Boyer
Ayman Al-Hendy
author_facet Qiwei Yang
Somayeh Vafaei
Ali Falahati
Azad Khosh
Maria Victoria Bariani
Mervat M. Omran
Tao Bai
Hiba Siblini
Mohamed Ali
Chuan He
Thomas G. Boyer
Ayman Al-Hendy
author_sort Qiwei Yang
collection DOAJ
description Bromodomain-containing proteins (BRDs) are involved in many biological processes, most notably epigenetic regulation of transcription, and BRD dysfunction has been linked to many diseases, including tumorigenesis. However, the role of BRDs in the pathogenesis of uterine fibroids (UFs) is entirely unknown. The present study aimed to determine the expression pattern of BRD9 in UFs and matched myometrium and further assess the impact of a BRD9 inhibitor on UF phenotype and epigenetic/epitranscriptomic changes. Our studies demonstrated that the levels of BRD9 were significantly upregulated in UFs compared to matched myometrium, suggesting that the aberrant BRD expression may contribute to the pathogenesis of UFs. We then evaluated the potential roles of BRD9 using its specific inhibitor, I-BRD9. Targeted inhibition of BRD9 suppressed UF tumorigenesis with increased apoptosis and cell cycle arrest, decreased cell proliferation, and extracellular matrix deposition in UF cells. The latter is the key hallmark of UFs. Unbiased transcriptomic profiling coupled with downstream bioinformatics analysis further and extensively demonstrated that targeted inhibition of BRD9 impacted the cell cycle- and ECM-related biological pathways and reprogrammed the UF cell epigenome and epitranscriptome in UFs. Taken together, our studies support the critical role of BRD9 in UF cells and the strong interconnection between BRD9 and other pathways controlling the UF progression. Targeted inhibition of BRDs might provide a non-hormonal treatment option for this most common benign tumor in women of reproductive age.
first_indexed 2024-03-08T09:54:03Z
format Article
id doaj.art-9eeca701841d46a9b58604e2a27340d4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T09:54:03Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-9eeca701841d46a9b58604e2a27340d42024-01-29T13:55:29ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-01-0125290510.3390/ijms25020905Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid CellsQiwei Yang0Somayeh Vafaei1Ali Falahati2Azad Khosh3Maria Victoria Bariani4Mervat M. Omran5Tao Bai6Hiba Siblini7Mohamed Ali8Chuan He9Thomas G. Boyer10Ayman Al-Hendy11Department of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USADNA GTx LAB, Dubai Healthcare City, Dubai 505262, United Arab EmiratesDepartment of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USAObstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USADepartment of Chemistry, University of Chicago, Chicago, IL 60637, USADepartment of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USADepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USABromodomain-containing proteins (BRDs) are involved in many biological processes, most notably epigenetic regulation of transcription, and BRD dysfunction has been linked to many diseases, including tumorigenesis. However, the role of BRDs in the pathogenesis of uterine fibroids (UFs) is entirely unknown. The present study aimed to determine the expression pattern of BRD9 in UFs and matched myometrium and further assess the impact of a BRD9 inhibitor on UF phenotype and epigenetic/epitranscriptomic changes. Our studies demonstrated that the levels of BRD9 were significantly upregulated in UFs compared to matched myometrium, suggesting that the aberrant BRD expression may contribute to the pathogenesis of UFs. We then evaluated the potential roles of BRD9 using its specific inhibitor, I-BRD9. Targeted inhibition of BRD9 suppressed UF tumorigenesis with increased apoptosis and cell cycle arrest, decreased cell proliferation, and extracellular matrix deposition in UF cells. The latter is the key hallmark of UFs. Unbiased transcriptomic profiling coupled with downstream bioinformatics analysis further and extensively demonstrated that targeted inhibition of BRD9 impacted the cell cycle- and ECM-related biological pathways and reprogrammed the UF cell epigenome and epitranscriptome in UFs. Taken together, our studies support the critical role of BRD9 in UF cells and the strong interconnection between BRD9 and other pathways controlling the UF progression. Targeted inhibition of BRDs might provide a non-hormonal treatment option for this most common benign tumor in women of reproductive age.https://www.mdpi.com/1422-0067/25/2/905uterine leiomyomaBRD9I-BRD9cell proliferationapoptosisextracellular matrix
spellingShingle Qiwei Yang
Somayeh Vafaei
Ali Falahati
Azad Khosh
Maria Victoria Bariani
Mervat M. Omran
Tao Bai
Hiba Siblini
Mohamed Ali
Chuan He
Thomas G. Boyer
Ayman Al-Hendy
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
International Journal of Molecular Sciences
uterine leiomyoma
BRD9
I-BRD9
cell proliferation
apoptosis
extracellular matrix
title Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
title_full Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
title_fullStr Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
title_full_unstemmed Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
title_short Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
title_sort bromodomain containing protein 9 regulates signaling pathways and reprograms the epigenome in immortalized human uterine fibroid cells
topic uterine leiomyoma
BRD9
I-BRD9
cell proliferation
apoptosis
extracellular matrix
url https://www.mdpi.com/1422-0067/25/2/905
work_keys_str_mv AT qiweiyang bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT somayehvafaei bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT alifalahati bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT azadkhosh bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT mariavictoriabariani bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT mervatmomran bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT taobai bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT hibasiblini bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT mohamedali bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT chuanhe bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT thomasgboyer bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells
AT aymanalhendy bromodomaincontainingprotein9regulatessignalingpathwaysandreprogramstheepigenomeinimmortalizedhumanuterinefibroidcells